Edgewise Therapeutics, Inc. (NASDAQ:EWTX) showed up in the 13F filings of 194 institutional investors as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 31 Mar, 2026 | 15,518,492 | 0 | 0.00% | $488,832,498.00 |
| ORBIMED ADVISORS LLC | 31 Mar, 2026 | 15,518,492 | 0 | 0.00% | $385,091,379.00 |
| Janus Henderson Group Plc | 31 Mar, 2026 | 11,831,112 | 7,264,262 | 159.07% | $372,578,164.00 |
| RA CAPITAL MANAGEMENT, L.P. | 31 Mar, 2026 | 10,428,437 | 0 | 0.00% | $328,495,766.00 |
| RA CAPITAL MANAGEMENT, L.P. | 31 Mar, 2026 | 10,428,437 | 0 | 0.00% | $258,781,664.00 |
| Paradigm Biocapital Advisors LP | 31 Mar, 2026 | 7,365,038 | 823,828 | 12.59% | $231,998,697.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 6,630,576 | 279,089 | 4.39% | $164,537,741.00 |
| BAKER BROS. ADVISORS LP | 31 Mar, 2026 | 6,575,940 | -730,000 | -9.99% | $163,181,951.00 |
| BAKER BROS. ADVISORS LP | 31 Mar, 2026 | 6,575,940 | 0 | 0.00% | $207,142,110.00 |
| Paradigm Biocapital Advisors LP | 31 Mar, 2026 | 6,541,210 | 371,079 | 6.01% | $162,320,126.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 6,472,991 | -157,585 | -2.38% | $203,899,220.00 |
| Novo Holdings A/S | 31 Mar, 2026 | 5,350,000 | 0 | 0.00% | $132,760,250.00 |
| Novo Holdings A/S | 31 Mar, 2026 | 5,350,000 | 0 | 0.00% | $168,525,000.00 |
| BRAIDWELL LP | 31 Mar, 2026 | 5,210,831 | 0 | 0.00% | $129,306,771.00 |
| VANGUARD GROUP INC | 31 Mar, 2026 | 4,871,624 | 67,683 | 1.41% | $120,889,349.00 |
| Janus Henderson Group Plc | 31 Mar, 2026 | 4,566,850 | -412,481 | -8.28% | $113,326,384.00 |
| Siren, L.L.C. | 31 Mar, 2026 | 4,529,990 | 632,891 | 16.24% | $112,411,702.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 4,477,942 | 286,749 | 6.84% | $141,055,173.00 |
| PERCEPTIVE ADVISORS LLC | 31 Mar, 2026 | 4,457,974 | 662,080 | 17.44% | $110,624,625.00 |
| Siren, L.L.C. | 31 Mar, 2026 | 4,430,263 | -99,727 | -2.20% | $139,553,285.00 |